Shuling Chen
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
Papers in
- Hepatology 30
- Hepatocellular Carcinoma Treatment and Prognosis 30
- Oncology 15
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Ming Kuang (34 shared papers)Kaiyu Sun (11 shared papers)Jianbo Xu (4 shared papers)Sui Peng (26 shared papers)Yulong He (2 shared papers)Zhenwei Peng (27 shared papers)Guanghua Li (2 shared papers)Xiao-yan Xie (16 shared papers)
- Journals
- European Radiology (8 papers)Hepatology (5 papers)Frontiers in Oncology (4 papers)Radiology (3 papers)BMC Cancer (3 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Shuling Chen
107 papers receiving 3.4k citations
Shuling Chen's Hit Papers
Peers
Comparison fields: 5 of 120
- Hepatology 966
- Oncology 678
- Cancer Research 348
- Radiology, Nuclear Medicine and Imaging 480
- Health Informatics 27
Countries citing papers authored by Shuling Chen
This map shows the geographic impact of Shuling Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuling Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuling Chen more than expected).
Fields of papers citing papers by Shuling Chen
This network shows the impact of papers produced by Shuling Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuling Chen. The network helps show where Shuling Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Shuling Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 356 | |
| 2 | 2019 | 167 | |
| 3 | 2018 | 160 | |
| 4 | 2019 | 150 | |
| 5 | 2019 | 134 | |
| 6 | 2022 | 134 | |
| 7 | 2021 | 109 | |
| 8 | 2015 | 84 | |
| 9 | 2018 | 75 | |
| 10 | 2022 | 69 | |
| 11 | 2021 | 69 | |
| 12 | 2018 | 64 | |
| 13 | 2020 | 63 | |
| 14 | 2018 | 63 | |
| 15 | 2022 | 63 | |
| 16 | 2014 | 60 | |
| 17 | 2019 | 60 | |
| 18 | 2018 | 56 | |
| 19 | Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures Hit paper breakdown → | 2025 | 54 |
| 20 | 2021 | 53 |
About Shuling Chen
Shuling Chen is a scholar working on Hepatology, Oncology, Surgery, Cancer Research and Pathology and Forensic Medicine, having authored 112 papers that have together received 3.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (30 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), RNA modifications and cancer (4 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Inflammatory Bowel Disease (4 papers). The work is most often cited by research in Hepatology (966 citations), Oncology (678 citations), Cancer Research (348 citations), Radiology, Nuclear Medicine and Imaging (480 citations) and Health Informatics (27 citations). Shuling Chen has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Ming Kuang, Kaiyu Sun, Jianbo Xu, Sui Peng, Yulong He, Zhenwei Peng, Guanghua Li, Xiao-yan Xie, Wei Wang and Shi‐Ting Feng. Their work appears in journals such as European Radiology, Hepatology, Frontiers in Oncology, Radiology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.